These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21220975)

  • 21. Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr 3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine.
    Kroiss A; Putzer D; Uprimny C; Decristoforo C; Gabriel M; Santner W; Kranewitter C; Warwitz B; Waitz D; Kendler D; Virgolini IJ
    Eur J Nucl Med Mol Imaging; 2011 May; 38(5):865-73. PubMed ID: 21279352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Case of 131I-meta-iodobenzylguanidine (MIBG) scintigraphy-negative and 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET)-positive pheochromocytoma].
    Jotoku M; Okura T; Nagao T; Enomoto D; Irita J; Miyoshi K; Kurata M; Fukuoka T; Higaki J
    Nihon Jinzo Gakkai Shi; 2009; 51(5):563-8. PubMed ID: 19715165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical value of [18F]fluoro-dihydroxyphenylalanine positron emission tomography in primary diagnosis, staging, and restaging of neuroendocrine tumors.
    Kauhanen S; Seppänen M; Ovaska J; Minn H; Bergman J; Korsoff P; Salmela P; Saltevo J; Sane T; Välimäki M; Nuutila P
    Endocr Relat Cancer; 2009 Mar; 16(1):255-65. PubMed ID: 19088184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of pheochromocytoma with negative MIBG scintigraphy, PET-CT and genetic tests (VHL included) and a rare case of post-operative erectile dysfunction.
    Defeudis G; Fioriti E; Palermo A; Tuccinardi D; Minucci A; Capoluongo E; Pozzilli P; Manfrini S
    Hormones (Athens); 2018 Jun; 17(2):279-284. PubMed ID: 29860716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imaging of pheochromocytoma and paraganglioma.
    Brink I; Hoegerle S; Klisch J; Bley TA
    Fam Cancer; 2005; 4(1):61-8. PubMed ID: 15883712
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Kroiss AS; Uprimny C; Shulkin BL; Gruber L; Frech A; Jazbec T; Girod PP; Url C; Thomé C; Riechelmann H; Sprinzl GM; Fraedrich G; Virgolini IJ
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(2):94-99. PubMed ID: 30630744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multimodality imaging of bilateral pheochromocytoma. A case report.
    Paladino NC; Lowery A; Guérin C; Taïeb D; Sebag F
    Ann Ital Chir; 2015 Jun; 86(ePub):. PubMed ID: 26208532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 68Ga-DOTANOC PET/CT for baseline evaluation of patients with head and neck paraganglioma.
    Sharma P; Thakar A; Suman K C S; Dhull VS; Singh H; Naswa N; Reddy RM; Karunanithi S; Kumar R; Kumar R; Malhotra A; Bal C
    J Nucl Med; 2013 Jun; 54(6):841-7. PubMed ID: 23520216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [11C]metahydroxyephedrine and [18F]fluorodeoxyglucose positron emission tomography improve clinical decision making in suspected pheochromocytoma.
    Mann GN; Link JM; Pham P; Pickett CA; Byrd DR; Kinahan PE; Krohn KA; Mankoff DA
    Ann Surg Oncol; 2006 Feb; 13(2):187-97. PubMed ID: 16418883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pheochromocytoma presenting with remote bony recurrence twenty years after initial surgery: detection with 68Ga-DOTANOC PET/CT.
    Parida GK; Dhull VS; Sharma P; Bal C; Kumar R
    Clin Nucl Med; 2014 Apr; 39(4):365-6. PubMed ID: 23640231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography (18F-DOPA PET/CT) for detecting pheochromocytoma.
    Luster M; Karges W; Zeich K; Pauls S; Verburg FA; Dralle H; Glatting G; Buck AK; Solbach C; Neumaier B; Reske SN; Mottaghy FM
    Eur J Nucl Med Mol Imaging; 2010 Mar; 37(3):484-93. PubMed ID: 19862519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [131I-meta-iodobenzylguanidine scintigraphy in patients with a suspected pheochromocytoma. A comparison with CT and biohumoral parameters].
    Maurelli L; Cuocolo A; Lastoria S; Brunetti A; Maurea S; Lembo G; Klain M; Caracò C; Salvatore M
    Radiol Med; 1991 Dec; 82(6):839-43. PubMed ID: 1788441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Adrenal incidentaloma and nuclear medicine examination].
    Tenenbaum F
    J Radiol; 2009 Mar; 90(3 Pt 2):444-8. PubMed ID: 19421135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 123I-MIBG, 18F-DOPA and 18F-FDG in a patient with MEN2 syndrome and recurrent pheochromocytoma.
    Cuenca-Cuenca JI; Marín-Oyaga VA; Borrego-Dorado I; Navarro-González E; Martos-Martínez JM; Vázquez-Albertino R
    Rev Esp Med Nucl Imagen Mol; 2013; 32(4):263-5. PubMed ID: 23434017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multifocal extra-adrenal paraganglioma evaluated with different PET tracers: comparison between 18F-FDG, 18F-DOPA and 68Ga DOTANOC PET/CT.
    Treglia G; Cardillo G; Stefanelli A; Di Franco D; Enang GN; Giordano A; Rufini V
    Clin Nucl Med; 2013 Dec; 38(12):e458-62. PubMed ID: 23486329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diuretic 68Ga DOTANOC PET/CT in imaging of bladder paraganglioma.
    Dhull VS; Karunanithi S; Arora S; Jain TK; Kumar R
    Clin Nucl Med; 2014 Oct; 39(10):915-6. PubMed ID: 24566403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations.
    Zelinka T; Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Reynolds JC; Ling A; Eisenhofer G; Lazúrová I; Adams KT; Whatley MA; Widimsky J; Pacak K
    Endocr Relat Cancer; 2008 Mar; 15(1):311-23. PubMed ID: 18310297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PET/Computed Tomography in Neuroendocrine Tumor: Value to Patient Management and Survival Outcomes.
    Shamim SA; Kumar A; Kumar R
    PET Clin; 2015 Jul; 10(3):411-21. PubMed ID: 26099675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pheochromocytomas: detection with 18F DOPA whole body PET--initial results.
    Hoegerle S; Nitzsche E; Altehoefer C; Ghanem N; Manz T; Brink I; Reincke M; Moser E; Neumann HP
    Radiology; 2002 Feb; 222(2):507-12. PubMed ID: 11818620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FDG PET in the evaluation of phaeochromocytoma: a correlative study with MIBG scintigraphy and Ki-67 proliferative index.
    Lin M; Wong V; Yap J; Jin R; Leong P; Campbell P
    Clin Imaging; 2013; 37(6):1084-8. PubMed ID: 24035263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.